MedicationsSemaglutide

How Ozempic
works inside
your body.

Ozempic injection contains semaglutide. When blood sugar is high, it helps the pancreas release more insulin and less glucagon. These signals help move sugar into tissues and reduce sugar released by the liver.[1][1][2][1][3]

semaglutide · generic name[1]

This page is specific to semaglutide injection sold as Ozempic.

Sources checked 2026-09-26 · No qualified clinical review recorded.

Original 60-second, 16:9 silent prototype. Its ending says Educational prototype. Read the written explanation, sources and review status below.

Read the scene-by-scene visual alternative

What is Ozempic?

Ozempic injection is approved alongside diet and exercise to improve blood-sugar control in adults with type 2 diabetes.[1]

See the uses & details

How it works
(in plain English)

Ozempic injection contains semaglutide. When blood sugar is high, it helps the pancreas release more insulin and less glucagon. These signals help move sugar into tissues and reduce sugar released by the liver.[1][1][2][1][3]

Two pathways that help lower high blood sugar.

What might you notice?

Commonly listed side effects include nausea, vomiting, diarrhea, constipation and abdominal pain. Read the Medication Guide for fuller safety information.[1][2]

Side effects vary. These are selected examples, not the full list.

Know the important watch-outs

Ozempic (semaglutide) injection only. This article focuses on glucose control in adults with type 2 diabetes. It does not cover Ozempic tablets, Wegovy, weight-loss treatment or other semaglutide products, and does not describe every approved use of Ozempic injection.[1]

The original video, in words

Original storyboard wording and timing are preserved below. Motion is schematic, not a measured clinical result. The chosen silent master has no audio; storyboard references to music describe the alternate original soundtrack.

  1. 0–5 seconds · The question

    How does Ozempic lower blood sugar?

    Blood-sugar control

    Visual: Glucose particles move through a schematic bloodstream. No efficacy number, blood-sugar target or before/after normalization is shown.

    [1]

  2. 5–13 seconds · The signal

    Semaglutide activates GLP-1 receptors.

    GLP-1 is a hormone that helps regulate blood sugar.

    Visual: A labeled semaglutide particle docks at a schematic cell-surface receptor, followed by an activation pulse.

    [1]

  3. 13–20 seconds · Insulin release

    When blood sugar is high

    The pancreas releases more insulin.

    Insulin is a hormone.

    Visual: The pancreas releases distinct cyan insulin signals toward a labeled muscle cell.

    [1][2]

  4. 20–27 seconds · Glucose uptake

    When blood sugar is high

    Insulin helps cells take up sugar.

    Sugar moves from the blood into body tissues.

    Visual: After the insulin signal reaches the muscle cell, orange glucose particles enter the cell. Blood keeps flowing.

    [1][2]

  5. 27–33 seconds · Glucagon

    When blood sugar is high

    Glucagon tells the liver to release sugar.

    Visual: Glucagon signals travel from the pancreas toward the liver. Glucose leaves the liver and enters the blood.

    [1][3]

  6. 33–39 seconds · Reduced glucose release

    When blood sugar is high

    Less glucagon. Less sugar released.

    Semaglutide reduces glucagon release.

    Visual: Signal frequency and glucose release are reduced, not stopped. Particle counts and motion are qualitative, not clinical measurements.

    [1][3]

  7. 39–47 seconds · Common side effects

    Common side effects

    Nausea

    Vomiting

    Diarrhea

    Constipation

    Stomach pain

    Other risks are listed in the Medication Guide.

    Visual: Stable, large type. The music becomes quieter; there is no celebratory or dramatic risk animation.

    [1][2]

  8. 47–56 seconds · Boxed warning

    Boxed warning

    Thyroid C-cell tumors in rodents.

    Human risk is unknown.

    More safety details in the companion notes.

    Visual: A dedicated warning panel with no implied human tumor imagery.

    [1]

  9. 56–60 seconds · Read further

    HowMedsWork

    Read the Medication Guide.

    Educational prototype

    Visual: Stable ending, with a short fade out.

    [1]

Read the Ozempic injection Medication Guide in the prescribing information (PDF)

The original short video does not contain all the safety context in this article. Read the selected warnings below and the full Medication Guide.

The play-by-play

Here’s what happens.

  1. 1

    A glucose-regulating signal

    Semaglutide activates GLP-1 receptors, which respond to a hormone involved in blood-sugar regulation.[1]

    Want the science?

    Semaglutide activates GLP-1 receptors, which respond to a hormone involved in blood-sugar regulation.[1]

  2. 2

    More insulin when glucose is high

    When blood sugar is high, semaglutide increases insulin release. Insulin helps sugar move from the blood into body tissues.[1][2]

    Want the science?

    When blood sugar is high, semaglutide increases insulin release. Insulin helps sugar move from the blood into body tissues.[1][2]

  3. 3

    Less sugar released by the liver

    Glucagon signals the liver to release stored sugar. When blood sugar is high, semaglutide reduces glucagon release, helping reduce this supply of sugar to the blood. This does not mean the signal or sugar release stops completely.[1][3]

    Want the science?

    Glucagon signals the liver to release stored sugar. When blood sugar is high, semaglutide reduces glucagon release, helping reduce this supply of sugar to the blood. This does not mean the signal or sugar release stops completely.[1][3]

The pictures and animations are simplified illustrations. They do not show an exact dose, timing, or what will happen for you.

What’s it used for?

The exact product, age, and condition matter. These are simplified examples from the approved labels.

FDA-approved · Ozempic injection (subcutaneous)

Blood-sugar control in type 2 diabetes

Ozempic injection is approved alongside diet and exercise to improve blood-sugar control in adults with type 2 diabetes.[1]

Adults with type 2 diabetes; alongside diet and exercise

What about off-label uses?

Sometimes a medicine is prescribed for a use outside its FDA-approved label. That is called “off-label.” It does not mean FDA has approved that use. Here’s the FDA’s explanation.

This first edition does not cover off-label uses for semaglutide. That does not mean none exist.

The watch-outs.

Boxed warning and contraindications

Semaglutide caused thyroid C-cell tumors in rodents; whether this risk applies to humans is unknown. Ozempic is contraindicated with a personal or family history of medullary thyroid carcinoma, MEN 2, or a serious allergy to semaglutide or its ingredients.[1]

Important risks include pancreatic inflammation, diabetic eye-disease complications, dehydration-related kidney injury, severe digestive reactions, serious allergy, and gallbladder problems. Low blood sugar is more likely with insulin or sulfonylureas. Aspiration has been reported around anesthesia or deep sedation. These are selected risks, not the complete safety information.[1]

Commonly listed side effects include nausea, vomiting, diarrhea, constipation and abdominal pain. Read the Medication Guide for fuller safety information.[1][2]

This is not a complete list of side effects, interactions, or instructions. Read the full label and ask your pharmacist about your prescription.

A good question to ask.

What does this one-minute explanation leave out?

This explanation focuses on two glucose-control pathways. It is not a guide to every effect, indication or risk of Ozempic injection. The full prescribing information and Medication Guide provide broader context.[1]

Bring your medication list to the conversation. Ask: “What should I expect, and what should I look out for?”

Don’t just take our word for it.

Each numbered link points to the source behind the statement. No qualified clinical review recorded.

  1. [1] Ozempic (semaglutide) injection — US prescribing information and Medication GuideNovo Nordisk — FDA-approved US prescribing information · Accessed 2026-09-26 · Source revision: 05/2026Relevant sections: 12.1 Mechanism of Action · 1 Indications and Usage · Boxed Warning; 4 Contraindications; 5.1 Risk of Thyroid C-Cell Tumors · 5.2–5.10 Warnings and Precautions; 7.1 Drug Interactions; Medication Guide · 6.1 Clinical Trials Experience; Medication Guide · 1 Indications and Usage; 12.1 Mechanism of Action; Medication Guide · Highlights: OZEMPIC (semaglutide) injection; 1 Indications and Usage
  2. [2] MedlinePlus — Semaglutide InjectionAHFS/ASHP Patient Medication Information via NLM MedlinePlus · Accessed 2026-09-26 · Source revision: 05/15/2026Relevant sections: Why is this medication prescribed? · What side effects can this medication cause?
  3. [3] MedlinePlus — Glucagon Injection (liver glucose-release context only)AHFS/ASHP Patient Medication Information via NLM MedlinePlus · Accessed 2026-09-26 · Source revision: 06/15/2025Relevant sections: Why is this medication prescribed? (liver glucose release only)
Find another medication